Ingevity Corp

NGVT
Exchange
NYSE
Industry
Chemicals & Allied Products
SEC CIK
0001653477

Price chart

Open-market purchases and sales by NGVT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 18, 20265:14 PM ETAug 14 – Aug 18, 2026Li David HPresident & CEOSSaleCommon Stock−10.09K$75.7702−$764.67K120.54K−7.7%SEC10b5-1
Aug 14, 20265:06 PM ETAug 12 – Aug 13, 2026Li David HPresident & CEOSSaleCommon Stock−10K$76.175−$761.75K130.64K−7.1%SEC10b5-1
Aug 4, 20265:14 PM ETAug 3, 2026Fisher Ryan C.SVP, Gen. Counsel & SecretarySSaleCommon Stock−2.71K$73.7164−$199.7K15.72K−14.7%SEC
Jun 1, 2026May 28, 2026DYER TERRANCE MSVP, Chief HR OfficerSSaleCommon Stock−496$68.4895−$33.97K7.2K−6.4%SEC
Mar 8, 2023Mar 7, 2023White Richard Allen JRSVP, Perf Chem and Pres, ISPTSSaleCommon Stock−1.44K$81.00−$116.56K6.53K−18.1%SEC

The largest institutional positions in NGVT at the end of Q2 2026.

Institutions holding NGVT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.5,364,204$400.55M0.01%+66,489+1.3%Added
VANGUARD PORTFOLIO MANAGEMENT LLC2,376,803$177.48M0.01%+200,072+9.2%Added
VANGUARD CAPITAL MANAGEMENT LLC1,571,127$117.32M0.00%−10,744−0.7%Reduced
STATE STREET CORP1,497,321$111.76M0.00%+38,086+2.6%Added
AMERICAN CENTURY COMPANIES INC1,270,958$94.9M0.04%−161,608−11.3%Reduced